Complete adenine phosphoribosyltransferase (APRT) deficiency causes 2,8-dihydroxyadenine urolithiasis. In previous reports, analysis of the kinetic properties of APRT from APRT-deficient Japanese subjects revealed strikingly similar abnormalities suggesting a distinct "Japanese-type" mutation. In this paper, we report studies of 11 APRT-deficient lymphoblast cell lines. Nucleotide sequence analysis of APRT genomic DNA from WR2, a Japanese-type homozygote, identified a T to C substitution in exon 5, giving rise to the substitution of threonine for methionine at position 136. RNase mapping analysis confirmed this mutation in WR2 and revealed that six other Japanese-type homozygotes carry the same mutation on at least one allele. The remaining Japanese subject, who does not express the Japanese-type phenotype, did not demonstrate this mutation. Southern blot analysis showed that all seven Japanese-type subjects were confined to one TaqI restriction fragment length polymorphism (RFLP) haplotype. These studies provide direct evidence for the nature of the mutation in the Japanese-type APRT deficiency.
Introduction
Adenine phosphoribosyltransferase (APRT)' catalyzes the formation of AMP from adenine and phosphoribosylpyrophosphate (PRPP). Deficiency of this enzyme in humans, which is inherited in an autosomal recessive manner, results in the accumulation of adenine and its major oxidation product, 2,8-dihydroxyadenine (2, . Since 2, 8 -DHA is relatively insoluble in urine, subjects with complete APRT deficiency often present with 2,8-DHA nephrolithiasis (1) .
Since Kelley and his colleagues described the first case of 1 . Abbreviations used in this paper: APRT, adenine phosphoribosyltransferase; 2,8-DHA, 2,8-dihydroxyadenine; PRPP, phosphoribosylpyrophosphate.
partial APRT deficiency in a heterozygote (2) , more than 50 affected families that include 49 homozygotes have been reported throughout the world. 13 homozygotes, from 12 families, are Caucasians while the other 36 homozygotes are Japanese. Human APRT has been extensively studied. The amino acid sequence of erythrocyte APRT has been determined (3) . The APRT gene is located on chromosome 16 (4) . It consists of five exons and four introns, which span 2.6 kilobases (kb) and encodes a protein of 180 amino acid residues (5, 6) . The nucleotide sequence of the normal human APRT gene has been determined (7, 8) .
The frequency of heterozygosity at the APRT locus has been estimated to be 0.4-1.1% from three surveys of erythrocyte APRT activity in Caucasian populations (9-1 1). Analysis of urinary stones in Japan indicates that the incidence of heterozygotes in the Japanese population is > 1.2% (12) . Thus, APRT deficiency is a common genetic disorder occurring at a frequency comparable to sickle cell anemia, thalassemia, hemophilia, and phenylketonuria (1) . It is likely that many patients with APRT deficiency remain undiagnosed.
Assays of erythrocyte APRT activity from 11 Caucasian homozygotes with 2,8-DHA nephrolithiasis showed < 3% of normal activity (1, 13, 14) . In contrast, 79% of Japanese subjects with APRT deficiency, i.e., "Japanese-type" mutants, have a mutant form of the enzyme with an altered Km for PRPP (12) . When cellular lysates from these subjects are assayed in vitro in the presence of saturating concentrations of PRPP, APRT activity is detectable. However, APRT activity is virtually absent in vivo in the presence of physiological concentrations of substrate. These subjects are thus phenotypically completely deficient. Cultured cells from these subjects remain viable in medium containing the adenine analogue, 6-methylpurine. This compound is toxic to cells that have APRT activity in vivo. This selective medium thus permits identification of functionally deficient cells. This finding suggests a distinct Japanese-type mutation possibly derived from a common progenitor with a single mutated APRT gene (12, 15) .
We have previously defined the mutations on both alleles from a Caucasian subject who was completely deficient in APRT activity. This subject was a compound heterozygote (16) . To define the spectrum of the mutations and specifically examine the possibility of a Japanese-type mutation, we studied the mutant APRT genes and mRNA from 11 lymphoblast cell lines derived from Caucasian and Japanese patients with APRT deficiency. (19) . The proteins in the gel were transferred electrophoretically to nitrocellulose paper in 0.7% acetic acid at 25 V for h by using Trans-Blot Cell (Bio-Rad Laboratories, Richmond, CA). The nitrocellulose paper was incubated with rabbit anti-human APRT at room temperature. After washing, the paper was incubated with 4 X lIO cpm of 1251-labeled protein A and autoradiographed (20) . Northern blot analysis. Total cytoplasmic RNA was prepared from cultured lymphoblasts according to the modified method of Chirgwin et al. (21) . Total cellular RNA (20 ug) was electrophoresed in a 0.8% agarose-formaldehyde gel and blot transferred to a Nytran paper (22) .
The paper was probed with a 0.54-kb Bam HI fragment of the normal APRT cDNA, pTO5, labeled by random oligonucleotide priming using [a-32P]dCTP (23) .
Southern blot analysis. Genomic DNA was extracted from cultured lymphoblasts (24) . After digestion with restriction endonucleases, the DNA fragments were electrophoresed in agarose gels, transferred to Nytran paper and probed with a 32P-labeled 2.2-kb Bam HI fragment of normal APRT genomic DNA (24) .
Genomic DNA cloning and sequencing. The genomic DNA from lymphoblasts was cloned into XgtlO (25) as previously described (16) . Approximately 100,000 plaques were obtained and screened by a standard procedure using the normal APRT cDNA as probe (24) . The genomic DNA inserts from positive clones were recloned into pUC 18 and subcloned into M 13 for sequencing. The nucleotide sequence was determined by the method of Sanger et al. (26) The anti-mRNA probes were synthesized from pG3R2 and pGSl as previously described (16) . The RNA was hybridized to the probe and digested with RNase A and RNase Tl as previously described (16 Northern blot analysis revealed that the size and amount of APRT mRNAs were grossly normal in all cell lines except for WRI 1, which had no detectable mRNA (data not shown). The amount of APRT mRNA from WRlO, a heterozygote from the family of WRI 1, was normal.
The Bam HI fragment of the APRT genomic DNA from WR2 was cloned into XgtlO. Four positive clones were obtained, recloned into pUC18, and designated p2B2, p2B7, p2B13, and p2B15. The nucleotide sequences of these four clones were determined and compared to that of the normal APRT gene previously determined in our laboratory (8) .
Several nucleotide differences were identified. First, in two clones, p2B2 and p2B7, a single nucleotide substitution, A to C, was identified at position 857 in intron 2 (Fig. 1 A) . In contrast, the same area of the sequence of p2B1 3 and p2B 15 was normal. These results indicate that p2B2 and p2B7 were derived from one allele, designated allele I, and p2B1 3 and p2B1 5 were derived from the other allele, designated allele II. This base difference between the two alleles does not affect the predicted amino acid sequence.
Secondly, a C to G transversion was found at position 998 in intron 2 ofall four clones (Fig. 1 B) predicted amino acid sequence of the protein and represents the previously described TaqI polymorphism within the APRT gene (6) . This TaqI polymorphism was confirmed by Southern blot analysis of WR2 genomic DNA. Thirdly, a T to C substitution, was identified at position 2069 in exon 5 of the genomic DNA from all four clones ( Fig.  1 C and D) . Thus, both alleles had the same nucleotide change at the same position within the coding sequence. This T to C transition predicts a methionine to threonine substitution at amino acid position 136.
No other abnormality in the coding sequence was found in the APRT genomic DNA of WR2. The Bam HI genomic DNA clones lack 35 bp at the 5' end of the coding region in exon 1. To exclude another mutation within this region, RNase mapping analysis was performed. The result of the RNase mapping analysis using RNA from WR2 cells and the RNA probe containing the 5'-flanking region and part of exon 1 was identical to that obtained using normal mRNA. Therefore, the T to C transition, which is the only nucleotide change in the coding region, seems to be responsible for the abnormal APRT protein from WR2 although the possibility that this represents a polymorphism has not been definitely excluded.
Secondary structure predictions were performed by analyzing the predicted amino acid sequences of normal and WR2 APRT by the method of Chou and Fasman (27, 28) . The structure of f3-sheet:#-turn:a-helix in the mutated area does not appear to be substantially changed by the amino acid substitution of threonine for methionine (data not shown).
RNase mapping analyses of cell lines with the Japanesetype phenotype (WR4, WR5, WR12, WR20, WR63, and WR77) were performed to determine if their genotypes were identical to that of WR2. The 199-nucleotide RNA probe protected from RNase should be cut into two pieces of 106 and 93 nucleotides if the T to C mutation identified in the WR2 gene is present in mRNA from these cell lines (Fig. 2 A) . In the lanes containing WR2, WR4, WR5, WR12, WR2O, WR63, and WR77, the expected 106-and 93-nucleotide long subbands were found, whereas the normal pattern was observed in the control, WIL2, (Fig. 2 B) . These results indicated that Japanese-type mutants have the same mutation as that found in WR2 on at least one allele. Because RNase mapping analysis of WR64 mRNA showed the same subbands, the single mutant allele ofthis heterozygote was also ofJapanese-type. RNA probe was completely digested from WRl 1, which is consistent with the absence of APRT mRNA in WRl cells. WR1O (heterozygote and the mother of WRl 1) also did not show subbands of 106 nucleotides and 93 nucleotides, indicating that WRi and WR10 do not have the Japanese-type mutation. Cell line 904, with an exon 4 deletion on one allele, showed a 112-nucleotide subband as predicted (16) .
When the TaqI site in intron 2 is present, a 2.1-kb band appears on Southern blot analysis. Otherwise, a 2.8-kb band should appear. Thus, three polymorphic haplotypes, represented by 2.1/2.1, 2.1/2.8, 2.8/2.8, in terms ofthe TaqI restriction fragment length polymorphism (RFLP) are possible. Southern blot analysis using TaqI revealed that all of Japanese-type mutants had only one 2.8-kb band, indicating that all of them were confined to a single TaqI polymorphic haplotype, 2.8/2.8 (Fig. 3) . The normal cell line, WIL2 and non-Japanese-type mutant, 904, had one 2.1-kb band (haplotype 2.1/2.1). WRl showed a 2.1-and a 1.8-kb band, suggesting that the former band reflected an intact TaqI site on one allele. The Japanese-type mutation appears in most of the patients with APRT deficiency in Japan whom we have studied. The occurrence of a common mutation in many unrelated families has been reported in f3-thalassemia (31) , hemophilia A (32), a,-antitrypsin deficiency (33) , phenylketonuria (34) , and Gaucher's disease (35) . In the first two diseases, a recurrent mutation at a "hot spot" has been proposed to explain the common occurrence of the mutation (31, 32) . In phenylketonuria, two particular mutations accounting for -60% ofthe cases suggest that mutant alleles might have spread in the population by positive selection or by random genetic drift (34) . Any of these mechanisms may explain the origin of the Japanese-type mutation.
The further study of the mutant alleles from subjects with APRT deficiency in different ethnic groups in Asia may elucidate the mechanism of the spread of the Japanese-type mutant allele. Additionally, survey of the Caucasian population for APRT deficiency may further delineate the spectrum of the mutations and help clarify their origins.
